KI
ABMD

Koch Industries’s Abiomed Inc ABMD Stock Holding History

Koch Industries’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,466
Closed -$650K – 997
2017
Q4 		$650K Sell
3,466
-2,615
-43% -$488K 0.1% 160
2017
Q3 		$1.03M Buy
6,081
+542
+10% +$82K 0.24% 44
2017
Q2 		$794K Buy
5,539
+3,567
+181% +$479K 0.22% 58
2017
Q1 		$247K Buy
+1,972
New +$229K 0.21% 153

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Koch Industries's ABMD Position: Q1 2018 in Review

Koch Industries sold out of Abiomed Inc (ABMD) in Q1 2018, closing a stake of 3,466 shares — an estimated $650K sold.

Koch Industries first reported a position in ABMD in Q1 2017 and held it in 4 quarters. The position peaked at $1.03M in Q3 2017. 405 funds tracked by Wall St. Rank hold ABMD as of Q1 2018.

  • Koch Industries reported no remaining Abiomed Inc position as of Q1 2018 after selling out during the quarter.
  • Koch Industries sold 3,466 Abiomed Inc shares in Q1 2018, an estimated $650K.
  • Koch Industries first reported a position in Abiomed Inc in Q1 2017 and held it in 4 quarters.
  • Koch Industries's Abiomed Inc position peaked at $1.03M in Q3 2017.
  • 405 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2018.

Based on Koch Industries's 13F filing for Q1 2018, filed 14 May 2018.